[
  {
    "ts": null,
    "headline": "CVS Health (CVS) Stock Moves -0.09%: What You Should Know",
    "summary": "CVS Health (CVS) closed at $45.78 in the latest trading session, marking a -0.09% move from the prior day.",
    "url": "https://finnhub.io/api/news?id=d2a0f64330f76ff4ca86a32b4d561faef9985d4936bbe45cc167e6a98f2d7837",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736289921,
      "headline": "CVS Health (CVS) Stock Moves -0.09%: What You Should Know",
      "id": 132311265,
      "image": "https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health (CVS) closed at $45.78 in the latest trading session, marking a -0.09% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=d2a0f64330f76ff4ca86a32b4d561faef9985d4936bbe45cc167e6a98f2d7837"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corp. stock outperforms competitors despite losses on the day",
    "summary": "CVS Health Corp. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=274a4ed2611a1e5d1d76e76dbfc7ded7df3e5a55cfdae0a52dc6e20c60522881",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736268660,
      "headline": "CVS Health Corp. stock outperforms competitors despite losses on the day",
      "id": 132329043,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "CVS Health Corp. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=274a4ed2611a1e5d1d76e76dbfc7ded7df3e5a55cfdae0a52dc6e20c60522881"
    }
  },
  {
    "ts": null,
    "headline": "Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?",
    "summary": "Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
    "url": "https://finnhub.io/api/news?id=d889e64fac2933f2e1e0002a164fc9d97e9dd1bdc53764795827a4f1090417c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736260212,
      "headline": "Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?",
      "id": 132311267,
      "image": "https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
      "url": "https://finnhub.io/api/news?id=d889e64fac2933f2e1e0002a164fc9d97e9dd1bdc53764795827a4f1090417c5"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health price target lowered to $60 from $67 at Truist",
    "summary": "Truist analyst David MacDonald lowered the firm’s price target on CVS Health (CVS) to $60 from $67 and keeps a Buy rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The firm sees the outlook for the group as “mixed”, with bullish stance on the underlying demand drivers and overarching sector tailwinds that include demographics, value-based care, and core demand being offset by heightened concern around a likely more cost focused government backdrop.",
    "url": "https://finnhub.io/api/news?id=cc24f1763091d0877d869fc4f67bd94f6d5e6c77f03d2394d08609fabbed67e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736254701,
      "headline": "CVS Health price target lowered to $60 from $67 at Truist",
      "id": 132311269,
      "image": "https://media.zenfs.com/en/tipranks_452/2646b462c9673c36a67e2a9b4d64112c",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Truist analyst David MacDonald lowered the firm’s price target on CVS Health (CVS) to $60 from $67 and keeps a Buy rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The firm sees the outlook for the group as “mixed”, with bullish stance on the underlying demand drivers and overarching sector tailwinds that include demographics, value-based care, and core demand being offset by heightened concern around a likely more cost focused government backdrop.",
      "url": "https://finnhub.io/api/news?id=cc24f1763091d0877d869fc4f67bd94f6d5e6c77f03d2394d08609fabbed67e1"
    }
  },
  {
    "ts": null,
    "headline": "Aetna sues drugmakers over alleged price-fixing scheme",
    "summary": "The complaint alleges nearly two dozen pharmaceutical companies colluded to limit competition, causing costs for certain generic medications to skyrocket.",
    "url": "https://finnhub.io/api/news?id=86cdad44be5999049911bf91b82c14a35a367ecd3fb092ad2b0a469027f7757b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736242234,
      "headline": "Aetna sues drugmakers over alleged price-fixing scheme",
      "id": 132311270,
      "image": "https://imgproxy.divecdn.com/ixxkb0OktZB_P1wmZ4D2E7V7_o2wJq-8gIAv2FbFmr0/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS8xMTE5MjE0OTA0NV8xYjM1Y2UyMTE1X2suanBn.webp",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "The complaint alleges nearly two dozen pharmaceutical companies colluded to limit competition, causing costs for certain generic medications to skyrocket.",
      "url": "https://finnhub.io/api/news?id=86cdad44be5999049911bf91b82c14a35a367ecd3fb092ad2b0a469027f7757b"
    }
  }
]